Effettua una ricerca
Luigi Cormio
Ruolo
Professore Associato
Organizzazione
Università degli Studi di Foggia
Dipartimento
Dipartimento di Scienze Mediche e Chirurgiche
Area Scientifica
Area 06 - Scienze mediche
Settore Scientifico Disciplinare
MED/24 - Urologia
Settore ERC 1° livello
LS - Life sciences
Settore ERC 2° livello
LS7 Diagnostic Tools, Therapies and Public Health: Aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics
Settore ERC 3° livello
LS7_4 Analgesia and Surgery
New targets and approaches are under investigation for the treatment of nonmuscle invasive bladder cancer (NMIBC). Preclinical data suggest cyclooxygenase-2 (COX-2) as a promising target. Celecoxib, a COX-2 selective inhibitor, inhibits tumor development and enhances survival, both in vitro and in vivo models of bladder cancer. Therefore, we conducted a pilot study of celecoxib to prevent recurrence in patients with intermediate risk NMIBC.
Condividi questo sito sui social